| Ident. | Authors (with country if any) | Title |
|---|
| 000209 |
Faraj Terro [France] ; Amandine Magnaudeix [France] ; Marion Crochetet [France] ; Ludovic Martin [France] ; Sylvie Bourthoumieu [France] ; Cornelia-M. Wilson [France] ; Catherine Yardin [France] ; Philippe Leveque [France] | GSM-900 MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy |
| 000353 |
Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada] | Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects |
| 000440 |
Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
| 000458 |
B. Pirotte [Belgique] ; P. Francotte [Belgique] ; E. Goffin [Belgique] ; P. Fraikin [Belgique] ; L. Danober [France] ; B. Lesur [France] ; I. Botez [France] ; D.-H. Caignard [France] ; P. Lestage [France] ; P. De Tullio [Belgique] | Ring-Fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor Potentiators |
| 000592 |
S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France] | Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide |
| 000722 |
A. Carmona [France, Espagne] ; G. Deves [France] ; R. Ortega [France] | Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques |
| 000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
| 000A09 |
Anne Clavreul [France] ; Laurence Sindji [France] ; Anne Aubert-Pouëssel [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France] ; Claudia N. Montero-Menei [France] | Effect of GDNF-releasing biodegradable micro spheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts |
| 000B01 |
Carmen Henze [France] ; Andreas Hartmann [France] ; Thomas Lescot [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] | Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism : role of granulocyte macrophage colony-stimulating factor |
| 000B21 |
Carmen Henze [France] ; Thomas Lescot [France] ; Sabine Traver [France] ; Bénédicte Salthun-Lassalle [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] ; Andreas Hartmann [France] | Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro |
| 000B63 |
A. Elbaz [France] ; P. Damier [France] | Épidémiologie de la maladie de Parkinson |
| 000B98 |
Hélène Legros [France] ; Marie-George Dingeval [France] ; Francois Janin [France] ; Jean Costentin [France] ; Jean-Jacques Bonnet [France] | Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: Relationships with 3,4-dihydroxyphenylacetaldehyde formation |
| 000C38 |
Anne Aubert-Pouëssel [France] ; Marie-Claire Venier-Julienne [France] ; Anne Clavreul [France] ; Michelle Sergent [France] ; Christophe Jollivet [France] ; Claudia N. Montero-Menei [France] ; Emmanuel Garcion [France] ; David C. Bibby [France] ; Philippe Menei [France] ; Jean-Pierre Benoit [France] | In vitro study of GDNF release from biodegradable PLGA microspheres |
| 000D57 |
Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
| 000E87 |
Jean Dessolin [France] ; Marie Schuler [France] ; Alice Quinart [France] ; Francesca De Giorgi [France] ; Leon Ghosez [France] ; Francois Ichas [France] | Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases? |
| 000E93 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France] | Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat |
| 000F13 |
Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Maria Chrisina Carrillo [Argentine] ; Ken-Ichi Kitani [Japon] ; Moussa B. H. Youdium [Israël] ; Makoto Naoi [Japon] | Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes |
| 000F14 |
Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France] | Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine |
| 000F23 |
Yoko Hirata [Japon] | Manganese-induced apoptosis in PC12 cells |
| 000F41 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 000F56 |
Yoshimi Misu [Japon] ; Nobuya Furukawa [Japon] ; Nobutaka Arai [Japon] ; Takeaki Miyamae [Japon] ; Yoshio Goshima [Japon] ; Kiyohide Fujita [Japon] | DOPA causes glutamate release and delayed neuron death by brain ischemia in rats |
| 000F69 |
Stéphane Le Crom [France] ; Delphine Prou [France] ; Philippe Vernier [France] | Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization |
| 000F73 |
A. Nicotra [Italie] ; S. H. Parvez [France] | Apoptotic molecules and MPTP-induced cell death |
| 001102 |
| LES FACTEURS NEUROTROPHIQUES NON-PROTEIQUES : SYNTHESE ET ACTIVITE |
| 001166 |
K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Ueda [Japon] ; F. Checler [France] | α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells |
| 001190 |
Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
| 001206 |
P. Missy [France] ; M-C Lanhers [France] ; Y. Grignon [France] ; M. Joyeux [France] ; D. Burnel [France] | In vitro and in vivo studies on chelation of manganese |
| 001218 |
D. Blum [Belgique, France] ; S. Torch [France] ; M.-F. Nissou [France] ; A.-L. Benabid [France] ; J.-M. Verna [France] | Extracellular toxicity of 6-hydroxydopamine on PC12 cells |
| 001226 |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
| 001299 |
F. Esclaire [France] ; G. Kisby [États-Unis] ; P. Spencer [États-Unis] ; J. Milne [États-Unis] ; M. Lesort [France] ; J. Hugon [France] | The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates Tau mRNA expression and excitotoxicity |
| 001323 |
R. S. El-Bacha [France] ; P. Netter [France] ; A. Minn [France] | Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells : protection by bovine serum albumin and formation of apomorphine-protein conjugates |
| 001326 |
M. G. Murer [Argentine] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | Levodopa in Parkinson's disease : Neurotoxicity issue laid to rest? |
| 001351 |
F. A. Dajas-Bailador [Uruguay] ; M. Asencio [Chili] ; C. Bonilla [Uruguay] ; M. C. Scorza [Uruguay] ; C. Echeverry [Uruguay] ; M. Reyes-Parada [Uruguay] ; R. Silveira [Uruguay] ; P. Protais [France] ; G. Russell [Nouvelle-Zélande] ; B. K. Cassels [Chili] ; F. Dajas [Uruguay] | Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission |
| 001364 |
P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France] | Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes |
| 001428 |
A. Boireau [France] ; M. Meunier [France] ; A. Imperato [France] | Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole |
| 001433 |
E. X. Albuquerque [États-Unis, Brésil] ; E. F. R. Pereira [États-Unis] ; M. F. M. Braga [États-Unis, Brésil] ; H. Matsubayashi [États-Unis] ; M. Alkondon [États-Unis] | Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine |
| 001436 |
M. Merad-Boudia [France] ; A. Nicole [France] ; D. Santiard-Baron [France] ; C. Saille [France] ; I. Ceballos-Picot [France] | Mitochondrial impairment as an early event in th process of apoptosis induced by glutathione depletion in neuronal cells : Relevance to Parkinson's disease |
| 001458 |
A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II" |
| 001536 |
D. Blum [France] ; Y. Wu [France] ; M. F. Nissou [France] ; S. Arnaud [France] ; A. L. Benabid [France] ; J. M. Verna [France] | p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells |
| 001553 |
P. P. Michel [France] ; M. Ruberg [France] ; Yves Agid [France] | Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside |
| 001563 |
V. France-Lanord [France] ; B. Brugg [France] ; P. P. Michel [France] ; Yves Agid [France] ; M. Ruberg [France] | Mitochondrial free radical signal in ceramide-dependent apoptosis : A putative mechanism for neuronal death in Parkinson's disease |
| 001566 |
F. Huguet [France] ; G. Page [France] ; P. Morel [France] ; C. Tallineau [France] ; A. Piriou [France] | MPTP toxicity in rat striatal slices : dopamine uptake alteration does not appear to be related to lipid peroxidation |
| 001580 |
L. J. Anghileri [France] ; P. Thouvenot [France] ; A. Bertrand [France] | Effects of iron complexes on brain calcium homeostasis |
| 001603 |
| Synthèse et pharmacologie de nouveaux inhibiteurs de la monoamine oxydase B |
| 001665 |
L. Taupenot [France] ; J. Ciesielski-Treska [France] ; G. Ulrich [France] ; S. Chasserot-Golaz [France] ; D. Aunis [France] ; M.-F. Bader [France] | Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells |
| 001670 |
F. N. Bolkenius [France] ; J. Verne-Mismer [France] ; J. Wagner [France] ; J. M. Grisar [France] | Amphiphilic α-tocopherol analogues as inhibitors of brain lipid peroxidation |
| 001678 |
| Utilisation et amélioration de l'adénovirus en tant que vecteur viral pour le tranfert de gènes |
| 001705 |
L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France] | Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives |
| 001724 |
F. N. Bolkenius [France] ; D. Monard | Inactivation of protease nexin-1 by xanthine oxidase-derived free radicals |
| 001957 |
L. J. Anghileri [France] | Effects of complexes iron and aluminium on brain calcium |
| 001A10 |
G. K. Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. Constantidinis | GABAA receptor complex function in frontal cortex membranes from control and neurological patients |
| 001B31 |
D. Scherman ; F. Darchen ; C. Desnos ; J. P. Henry | 1-Methyl-4-phenylpyridinium is a substrate of the vesicular monoamine uptake system of chromaffin granules |
